Addition Therapeutics Investors 2026

Addition Therapeutics — investors and similar companies (54)

Addition Therapeutics's investor syndicate for 2026, drawn from verified round records: 6 distinct firms and angels appear on the cap table, including SR One, Pivotal Life Sciences, Abingworth, Osage University Partners, the Gates Foundation, BEVC. Addition Therapeutics is tracked in Biotech and headquartered in South San Francisco, CA.

The companies listed below are ranked by how much of that syndicate they share, so the overlap you see is backer-based rather than sector-based. Every investor name links to that firm's own profile with its full tracked portfolio, and every company links to its funding record.

• Verified backers on record: 6
• Total disclosed funding: $100M
• Latest tracked round: null (2025-12-17)
• Sector: Biotech
• Headquarters: South San Francisco, CA

• SR One
• Pivotal Life Sciences
• Abingworth
• Osage University Partners
• the Gates Foundation
• BEVC
• Ascend — shares Abingworth
• River 3 Renal — shares SR One
• Design Therapeutics — shares SR One
• Q32 Bio — shares Osage University Partners +1
• Attralus — shares Abingworth
• Rezo Therapeutics — shares SR One
• AdvanCell — shares Abingworth
• Poplar Therapeutics — shares SR One
• Morphic Therapeutic — shares SR One
• Aptinyx — shares Osage University Partners
• Venatorx Pharmaceuticals, Inc. — shares Abingworth
• VeraDermics — shares SR One
• MiroBio — shares SR One
• Crystalys Therapeutics — shares SR One
• CHARM Therapeutics — shares SR One
• Avenzo Therapeutics — shares SR One
• OncXerna Therapeutics — shares Osage University Partners
• Psioxus Therapeutics — shares SR One
• Draig Therapeutics — shares SR One
• Kate Therapeutics — shares Osage University Partners
• MicroTransponder — shares Osage University Partners
• Arkuda Therapeutics — shares Pivotal Life Sciences
• Aristea Therapeutics — shares SR One
• Entact Bio — shares Abingworth
• Gracell Biotechnologies — shares Pivotal Life Sciences
• Asceneuron — shares SR One
• Avila Therapeutics — shares Abingworth
• Cyteir Therapeutics — shares Osage University Partners
• Opsys Tech — shares Osage University Partners
• Antares Therapeutics — shares Abingworth
• Normunity — shares Osage University Partners
• Escient Pharmaceuticals — shares Abingworth +1
• Cytospire Therapeutics — shares Abingworth
• Kymeta — shares Osage University Partners
• ENYO Pharma — shares SR One
• Pixium Vision — shares Abingworth
• Overland AI — shares Osage University Partners
• IFM Therapeutics — shares Abingworth
• cAMPfield Therapeutics — shares Abingworth
• Ascend Gene & Cell Therapies — shares Abingworth
• GenSight Biologics — shares Abingworth
• Precede Biosciences — shares Osage University Partners
• Alumis — shares SR One
• Nido Biosciences — shares Abingworth +1
• StreetLight Data — shares Osage University Partners
• Palleon Pharmaceuticals — shares SR One
• Aileron Therapeutics — shares SR One
• Timberlyne Therapeutics — shares Abingworth

Addition Therapeutics funding profile · All research reports